Pregnancy loss in the antiphospholipid-antibody syndrome - A possible thrombogenic mechanism

New England Journal of Medicine

Volumn 337, Issue 3, 1997, Pages 154-160

  Rand, Jacob H ^a,e   Wu, Xiao Xuan ^a   Andree, Harry A M ^b   Lockwood, Charles J ^d   Guller, Seth ^d   Scher, Jonathan ^c   Harpel, Peter C ^a  

^a Divisions of Hematology ^*  (United States)

^b Thrombosis   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; LIPOCORTIN 5; PHOSPHOLIPID ANTIBODY; PROCOAGULANT;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; ENDOTHELIUM CELL; FETUS WASTAGE; HUMAN; HUMAN CELL; PREGNANCY COMPLICATION; PRIORITY JOURNAL; THROMBOGENESIS; TROPHOBLAST; UMBILICAL VEIN;

ABORTION, SPONTANEOUS; ANNEXIN A5; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BLOOD COAGULATION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; IMMUNOGLOBULIN G; PREGNANCY; REFERENCE VALUES; TROPHOBLASTS; UMBILICAL VEINS;

EID: 0030789659     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199707173370303     Document Type: Article

References (29)

1. Shapiro SS. The lupus anticoagulant/antiphospholipid syndrome. Annu Rev Med 1996;47:533-53.
2. Lockwood CJ, Rand JH. The immunobiology and obstetrical consequences of antiphospholipid antibodies. Obstet Gynecol Surv 1994;49: 432-41.
3. Lockshin MD. Antiphospholipid antibody and antiphospholipid antibody syndrome. Curr Opin Rheumatol 1991;3:797-802.
4. Asherson RA, Khamashta MA, Ordi-Ros J, et al. The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 1989;68:366-74.
5. Sammaritano LR, Gharavi AE, Lockshin MD. Antiphospholipid antibody syndrome: immunologic and clinical aspects. Semin Arthritis Rheum 1990;20:81-96.
6. Triplett DA. Protean clinical presentation of antiphospholipid-protein antibodies (APA). Thromb Haemost 1995;74:329-37.
7. Huber R, Berendes R, Burger A, Luecke H, Karshikov A. Annexin V: crystal structure and its implications on function. In: Moss SE, ed. The annexins. London: Portland Press, 1994:105-24.
8. Andree HAM, Hermens VVT, Hemker HC, Willems GM. Displacement of factor Va by annexin V. In: Andree HAM, ed. Phospholipid binding and anticoagulant action of annexin V. Maastricht, the Netherlands: Universitaire Pers Maastricht, 1992:73-85.
9. Krikun G, Lockwood CJ, Wu XX, et al. The expression of the placental anticoagulant protein, annexin V, by villous trophoblasts: immunolocalization and in vitro regulation. Placenta 1994;15:601-12.
10. Rand JH, Wu XX, Guller S, et al. Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion. Am J Obstet Gynecol 1994;171:1566-72.
11. Sammaritano LR, Gharavi AE, Soberano C, Levy RA, Lockshin MD. Phospholipid binding of antiphospholipid antibodies and placental anticoagulant protein. J Clin Immunol 1992;12:27-35.
12. Ornstein MH, Rand JH. An association between refractory HELLP syndrome and antiphospholipid antibodies during pregnancy: a report of 2 cases. J Rheumatol 1994;21:1360-4.
13. Kohler PO, Bridson WE. Isolation of hormone-producing clonal lines of human choriocarcinoma. J Clin Endocrinol Metab 1971;32:683-7.
14. Messmore H, Fabbrini N, Hoppensteadt D, Larach F, Fareed J. Lupus anticoagulant assays. Semin Thromb Hemost 1994;20:79-88.
15. Flaherty MJ, West S, Heimark RL, Fujikawa K, Tait JF. Placental anticoagulant protein-I: measurement in extracellular fluids and cells of the hemostatic system. J Lab Clin Med 1990;115:174-81.
16. Douglas GC, King BF. Isolation of pure villous cytotrophoblast from term human placenta using immunomagnetic microspheres. J Immunol Methods 1989;119:259-68.
17. Kliman HJ, Nestler JE, Sermasi E, Sanger JM, Strauss JF III. Purification, characterization, and in-vitro differentiation of cytotrophoblast from human term placentae. Endocrinology 1986;118:1567-82.
18. Hinegardner RT. An improved fluorometric assay for DNA. Anal Biochem 1971;39:197-201.
19. Jaffe EA, Hoyer LW, Nachman RL. Synthesis of antihemophilic factor antigen by cultured human endothelial cells. J Clin Invest 1973;52:2757-64.
20. Branch DW, Dudley DJ, Mitchell MD, et al. Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: a model for autoimmune fetal loss. Am J Obstet Gynecol 1990;163:210-6.
21. Blank M, Faden D, Tincani A, et al. Immunization with anticardiolipin cofactor (beta-2-glycoprotein-I) induces experimental antiphospholipid syndrome in naive mice. J Autoimmun 1994;7:441-55.
22. Krause I, Blank M, Gilbrut B, Shoenfeld Y. The effect of aspirin on recurrent fetal loss in experimental antiphospholipid syndrome. Am J Reprod Immunol 1993;29:155-61.
23. Pierangeli SS, Harris EN. In vivo models of thrombosis for the antiphospholipid syndrome. Lupus 1996;5:451-5.
24. Tait JF, Sakata M, McMullen BA, et al. Placental anticoagulant proteins: isolation and comparative characterization of four members of the lipocortin family. Biochemistry 1988;27:6268-76.
25. Tait JF, Gibson D, Fujikawa K. Phospholipid binding properties of human placental anticoagulant protein-I, a member of the lipocortin family. J Biol Chem 1989;264:7944-9.
26. Hajjar KA, Guevara CA, Lev E, Dowling K, Chacko J. Interaction of the fibrinolytic receptor, annexin II, with the endothelial cell surface: essential role of endonexin repeat 2. J Biol Chem 1996;271:21652-9.
27. Roubey RAS. Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other "antiphospholipid" autoantibodies. Blood 1994;84:2854-67.
28. Hasegawa I, Suzuki T, Ishii S, Takakuwa K, Tanaka K. Establishment of two distinct anti-cardiolipin antibody-producing cell lines from the same individual by Epstein-Barr virus transformation. Thromb Res 1994;74:77-84.
29. Andree HAM, Stuart MCA, Hermens WT, et al. Clustering of lipid-bound annexin V may explain its anticoagulant effect. J Biol Chem 1992; 267:17907-12.